TipRanks
Go Ultimate55% OFF

PolyPid (PYPD) Drug Pipeline

Drug pipeline
Drug NameConditionStageStatusStudy NameTrial Start DateArticle
Standard Of Care, D-PlexSurgical Site Infection, Colon Surgery, Abdominal Surgery, Post-Op InfectionPhase IIICompletedD-PLEX 312 - Safety and Efficacy of D-PLEX in the Prevention of Post Abdominal Surgery Incisional Infection (SHIELD II)May 27, 2020―
Standard Of Care, D-PlexSurgical Site Infection, Colon Surgery, Abdominal Surgery, Post-Op InfectionPhase IIICompletedD-PLEX 311: Safety and Efficacy of D-PLEX in the Prevention of Post Abdominal Surgery Incisional InfectionJan 06, 2020―
Standard Of Care, D-PlexColon Surgery, Abdominal Surgery, Post-Op InfectionPhase IICompletedD-PLEX 310: Safety and Efficacy of D-PLEX in the Prevention of Post Abdominal Surgery Incisional InfectionJun 21, 2018―

FAQ

What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases: a. Preclinical testing b. Phase 1 – Safety and dosage c. Phase 2 – Effectiveness and side effects d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does PolyPid Ltd. (PYPD) have in its pipeline
PolyPid PYPD is currently developing the following drugs: Standard Of Care, D-Plex. These drug candidates are in various stages of clinical development as the company works toward FDA approval.